Abstract
The aim of the study was evaluation of clinical and laboratory manifestations of drug-induced cytolytic syndrome in pregnancy. In the research group included 62 pregnant women with drug-induced liver injury (DILI) in the first trimester of pregnancy. These pregnant women received hormone therapy at the planning stage and/or during pregnancy for the prevention and treatment of miscarriage and had clinical and biochemical manifestations of cytolytic syndrome. Pregnancy after IVF and ovulation induction was in 60.8% of cases. Hormone therapy for pregnant patients received long-term, 85% of pregnant women used estrogen and progestin drugs. DILI during pregnancy characterized by low-symptom or asymptomatic clinical manifestations. DILI manifested cytolytic biochemical syndrome, in which there is isolated increase of transaminase levels, in some cases accompanied by increased level of gamma glutamyl transpeptidase, liver glutamate dehydrogenase and decreased total protein levels, in the first place due to the albumin fraction.
Highlights
■■Целью работы явилась оценка клинико-лабораторных проявлений лекарственно индуцированного цитолитического синдрома при беременности
Pregnancy after IVF and ovulation induction was in 60.8% of cases
drug-induced liver injury (DILI) during pregnancy characterized by low-symptom or asymptomatic clinical manifestations
Summary
Лекарственно-индуцированный цитолитический синдром при беременности: клинические и биохимические критерии диагностики. В группу исследования включены 62 беременных с наличием лекарственно индуцированного поражения печени (ЛИПП) в I триместре, которые получали гормональную терапию на этапе планирования и/или при беременности для профилактики и лечения невынашивания и имели клинико-биохимические проявления цитолитического синдрома. In the research group included 62 pregnant women with drug-induced liver injury (DILI) in the first trimester of pregnancy These pregnant women received hormone therapy at the planning stage and/or during pregnancy for the prevention and treatment of miscarriage and had clinical and biochemical manifestations of cytolytic syndrome. В своем исследовании R.A. Jackson (2004) заметил, что у женщин с одноплодной беременностью после ЭКО (даже в случае бесплодия по мужскому фактору) отмечалась высокая частота невынашивания беременности, тяжелого гестоза и перинатальной смертности по сравнению с женщинами, у которых беременность наступила в естественном цикле [18]. Целью работы явилась оценка клинико-лабораторых проявлений лекарственно индуцированного цитолитического синдрома при беременности
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
